Brazilian researchers contribute to advancing cancer treatment at Yale Cancer Center
Yale has long been a center for cancer research and innovation, dating back to its 1942 discovery of chemotherapy. Today, as one of the 57 designated comprehensive cancer centers in the U.S., Yale Cancer Center continues to be a hub for advancing the understanding and treatment of cancer.
For medical professionals from abroad, Yale offers a unique environment to contribute to cutting-edge research, access global resources, and collaborate on solutions for cancer care worldwide. Two Brazilian oncologists, Dr. Adriana Kahn and Dr. Philippos Apolinario Costa, are among the researchers at Yale working to expand knowledge and improve treatments for patients with cancer.
For these researchers from Brazil — as well as other medical professionals from across the globe — Yale provides the resources, mentorship, and global networks necessary to make significant contributions to cancer research. With its strong commitment to international collaboration, Yale continues to attract leading scientists worldwide, offering them the platform to develop new treatments, expand clinical trials, and bring innovations back to their home country.